10.1002/ejoc.201801751
European Journal of Organic Chemistry
COMMUNICATION
focusing on the synthesis of related natural products is underway
and will be reported in due course.
Experimental Section
Method: Antimicrobial susceptibility testing was performed by
measuring the minimum inhibitory concentration (MIC) by broth
microdilution. S. aureus ATCC 6538 was grown overnight (16 h)
at 37°C with shaking at 200 rpm in Cation Adjusted Mueller Hinton
II Broth (CAMHB) (BD BBL™). The following day a cell
suspension was prepared by diluting the overnight culture to an
optical density (OD600) of 0.003 in CAMHB. A 96 well polystyrene
plate was then set up to contain a 2-fold dilution series of each
compound in 50 μL CAMHB. The cell suspension (50 μL) was
then added to the diluted compounds yielding an OD600 (final) of
0.0015 in 100 μL (final) to ensure that the cell concentration was
adjusted to approximately 5 x 105 CFU/ml. Media, compound-free
(untreated), and DMSO vehicle controls were also included. The
plates were then incubated for 24 h at 37°C with shaking at 200
rpm. The MIC was reported as the lowest concentration of the test
compound for which no growth occurred. Experiments were
performed with biological replicates.
Scheme 3. The synthesis of isoxycyclointegrin (5)
Keywords: flavone • natural product • total synthesis • oxepine•
antibacterial
Vinylpyran 19, integrin (4) and oxyisocyclointegrin (5) were found
to possess moderate to weak activity against Staphylococcus
aureus (Table 1). Oxyisocyclointegrin (5) possessed weak activity
against prostate cancer cells (LnCap).
[1]
[2]
E. H. Hakim, S. A. Achmad, L. D. Juliawaty, L. Makmur, Y. M. Syah, N.
Aimi, M. Kitajima, H. Takayama, E. L. Ghisalberti, J. Nat. Med. 2006, 60,
161-184.
Table 1. Antibacterial activity
a) J. Xue, R. Li, X. Zhao, C. Ma, X. Lv, L. Liu, P. Liu, Chem. Biol. Interact.
2018, 283, 59-74; b) Y.-R. Liao, P.-C. Kuo, W.-J. Tsai, G.-J. Huang, K.-
H. Lee, T.-S. Wu, Bioorg. Med. Chem. Lett. 2017, 27, 309-313; c) F. Oke-
Altuntas, G. D. W. F. Kapche, J. L. Nantchouang Ouete, I. Demirtas, M.
B. Koc, B. T. Ngadjui, Med. Chem. Res. 2016, 25, 2250-2257; d) A. T.
Mbaveng, L. P. Sandjo, S. B. Tankeo, A. R. Ndifor, A. Pantaleon, B. T.
Nagdjui, V. Kuete, SpringerPlus 2015, 4, 823; e) N. T. Dat, P. T. X. Binh,
L. T. P. Quynh, C. Van Minh, H. T. Huong, J. J. Lee, Fitoterapia 2010,
81, 1224-1227; f) H. Y. Sohn, K. H. Son, C. S. Kwon, G. S. Kwon, S. S.
Kang, Phytomedicine 2004, 11, 666-672.
S. aureus ATCC
6538
LnCap
IC50 (M)
Compound[a]
MIC (g/mL)
Vinylpyran 19
16-32
32-64
128
60
60
16
Integrin (4)
Oxyisocyclointegrin (5)
Penicillin G (control)
[3]
[4]
A. D. Pendse, R. Pendse, A. V. R. Rao, K. Venkataraman, Indian J.
Chem., Sect. B 1976, 14B, 69-72.
0.03125
B. E. Swaney, S. Gai, M. R. Clark, B. C. Hawkins, Chemistry – An Asian
Journal, 0.
[5]
[6]
[7]
[8]
[9]
R. C. R. Wootton, University of Salford 2000.
Conclusions
D. Lim, Fang, G. Zhou, D. M. Coltart, Org. Lett. 2007, 9, 4139-4142.
B. E. Swaney, S. Gai, M. R. Clark, B. C. Hawkins, Chem. Asian. J.
N. Ayyagari, J. D. Belani, Synlett 2014, 25, 2350-2354.
See supporting information.
In conclusion, we have reported the first total synthesis of integrin
and oxyisocyclointegrin, these compounds were found to possess
moderate antibacterial activity against S. aureus. Future work
[10] T. Nomura, T. Fukai, S. Yamada, M. Katayanagi, Chem. Pharm. Bull
1978, 26, 1431-1436.
This article is protected by copyright. All rights reserved.